复杂腹主动脉瘤FBEVAR术后一年瘤囊稳定预示总生存与中期结局劣于瘤囊回缩
这项多中心回顾性观察研究纳入2015至2022年因短颈肾下、近肾、肾旁及肾旁内脏型腹主动脉瘤接受开窗/分支腔内修复(FBEVAR)的连续患者,排除一年时瘤囊扩张者,比较瘤囊回缩组与稳定组结局。一年瘤囊稳定组四年估计总生存低于回缩组(57.2 vs 87.5%,p = .029),一年瘤囊回缩是生存的独立预测因素(HR 3.11,p = .050)。
要点
- 一年瘤囊回缩组四年估计总生存高于瘤囊稳定组(87.5 vs 57.2%,p = .029)。
- 一年瘤囊回缩是生存的独立预测因素(HR 3.11,p = .050)。
- 瘤囊稳定组四年无再干预率数值较低但无统计学显著差异(89.2 vs 94.4%,p = .11)。
核心结论
- FBEVAR术后瘤囊动态变化与复杂腹主动脉瘤患者中期结局相关,一年瘤囊回缩预示更好的结局与生存,提示对瘤囊稳定患者需更密切监测。
研究设计与样本
- 多中心、回顾性、观察性研究,纳入2015至2022年因短颈肾下、近肾、肾旁及肾旁内脏型腹主动脉瘤接受FBEVAR的连续患者,排除一年时瘤囊扩张者,比较瘤囊回缩组与瘤囊稳定组,队列共98例(回缩36例、稳定62例),中位随访34个月(四分位距32)。
主要发现
- 四年估计总生存瘤囊稳定组低于瘤囊回缩组(57.2 vs 87.5%,p = .029)。
- 四年无再干预率瘤囊稳定组 vs 瘤囊回缩组为89.2 vs 94.4%(p = .11)。
- 末次随访时四年瘤囊回缩估计值瘤囊回缩组高于瘤囊稳定组(94.7 vs 46%,p < .001)。
- 四年无主动脉相关死亡瘤囊稳定组 vs 瘤囊回缩组为96.6 vs 100%(p = .26),无内漏为66.3 vs 90.2%(p = .035),无累积不良事件为89.7 vs 94.4%(p = .080)。
- Cox回归显示处理全部肾与内脏血管(HR 2.18,p = .035)及一年瘤囊回缩(HR 2.37,p = .015)为随访瘤囊回缩的独立预测因素,存在内漏(HR 0.31,p = .050)预测无瘤囊回缩。
关键数值与推荐
- 一年瘤囊回缩是生存的独立预测因素(HR 3.11,p = .050)。
- 处理全部肾与内脏血管是随访瘤囊回缩的独立预测因素(HR 2.18,p = .035)。
- 一年瘤囊回缩是随访瘤囊回缩的独立预测因素(HR 2.37,p = .015)。
- 存在内漏预测无瘤囊回缩(HR 0.31,p = .050)。
临床怎么用
- FBEVAR术后应关注一年瘤囊动态,瘤囊回缩者中期结局与生存较好,瘤囊稳定者需更密切监测。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This multicentre, retrospective, observational study investigated the correlation between sac dynamics and outcomes in patients with complex abdominal aortic aneurysms (AAAs) after fenestrated and branched endovascular repair (FBEVAR). METHODS: Consecutive patients undergoing FBEVAR for short neck infrarenal, juxtarenal, pararenal, and paravisceral AAAs between 2015 and 2022 were included. Based on one year sac dynamics, patients with sac expansion were excluded. Comparisons were made between patients with sac regression and those with sac stability. Primary endpoints included overall survival, freedom from re-interventions, and last follow up sac regression. Secondary outcomes included freedom from aorta related death, freedom from any endoleak, and freedom from cumulative adverse events. RESULTS: The study cohort included 98 patients, 36 with sac regression and 62 with sac stability at one year. Median follow up was 34 months (interquartile range 32). The four year estimated overall survival was lower for patients with sac stability (57.2 vs. 87.5%, p = .029), which also demonstrated a lower freedom from re-interventions (89.2 vs. 94.4%, p = .11). The four year estimates of last follow up sac regression were statistically significantly higher in those with initial sac regression (46 vs. 94.7%, p < .001). Cox regression analysis identified treatment of all renal and visceral vessels (hazard ratio [HR] 2.18, p = .035) and sac regression at one year (HR 2.37, p = .015) as independent predictors of follow up sac regression. Conversely, the presence of an endoleak (HR 0.31, p = .050) predicted the absence of sac regression. One year sac regression was an independent predictor of survival (HR 3.11, p = .050). Freedom from aorta related death (96.6 vs. 100%, p = .26), endoleak (66.3 vs. 90.2%, p = .035), and cumulative adverse events (89.7 vs. 94.4%, p = .080) were in favour of patients with sac regression. CONCLUSION: Sac dynamics correlate with midterm outcomes after FBEVAR for complex AAAs. One year sac regression predicted better outcomes and survival, suggesting the need for closer surveillance in patients with stable sacs.
引用
- Esposito D, Kaartama T, Bastianon M, et al. One Year Stable Sac Predicts Worse Overall Survival and Midterm Outcomes Compared with Sac Regression after Complex Abdominal Aortic Aneurysm Repair with Fenestrated and Branched Endografts. Eur J Vasc Endovasc Surg. 2025. PMID: 40541651. doi:10.1016/j.ejvs.2025.06.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。